Bayesian Population Pharmacokinetic Modeling of Ondansetron for Neonatal Opioid Withdrawal Syndrome
Clin Transl Sci. 2025 Feb;18(2):e70147. doi: 10.1111/cts.70147. ABSTRACT Ondansetron is an anti-emetic 5-HT3 receptor antagonist being investigated for treating neonatal opioid withdrawal syndrome (NOWS). Sparse …